Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

WhiteOak Capital Mutual Fund

WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

★★★★★ TopFund est.

TopFund Score (fallback rating)

  • Calculated by: TopFund — used only when no third-party rating exists for this fund
  • Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis

Full rating methodology →

TopFund Score: 72/100 · Good

How this score is calculated

  • Star rating (35%)4/5
  • 3Y CAGR (30%)—
  • Expense ratio (20%)1.06%
  • AUM (15%)₹1,003 Cr

Not investment advice — an analytical read of public fund data. Methodology →

WhiteOak Capital Mutual Fund · Equity · Sectoral

₹17.8

+0.83 (+4.9%)

AUM: ₹1,002 Cr

NAV updated 14 days ago

Plan

Regular

Option

Growth

Risk

Very High

Expense Ratio

1.06%

Exit Load

Nil

Fund Manager

Ashish Agrawal

Inception

Feb 2024

Benchmark

BSE Healthcare Total Return Index

Sharpe Ratio

1.09

Std Dev (1Y)

14.05%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+4.29%

3m

+2.5%

6m

+17.96%

1y

+20.62%

3y

—

5y

—

10y

—

since inception

+20.95%

TopFund's Take on WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth holds up reasonably well within the Sectoral category, backed by a 4-star rating. Recent 1-year performance has been notably strong, though momentum like this doesn't always hold over longer periods. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 72/100.

Cost: At 1.06%, the expense ratio is roughly in line with the Sectoral category average of 1.0% — cost isn't a standout factor either way for this fund.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a strong Sharpe ratio of 1.09 — the fund has generated solid returns relative to the volatility it exposed investors to. Separately, annualised volatility of 14.05% is fairly typical for Sectoral funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Healthcare 87.06%
Materials 4.36%
Financial 2.92%

Asset Allocation

Equity 83.83%
Futures 7.59%
CBLO 5.13%
Treasury Bills 2.92%
Net Receivables 0.53%

Frequently Asked Questions about WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.